Skip to content
Review Open access

Bone Metastasis and the Immunosuppressive Tumor Microenvironment: Mechanisms and Therapeutic Strategies

Oct 2026 · Oncology Research · Vol 34 · 0 citations · 65 references
Medicine

Abstract

Numerous solid tumours have bone as one of their most common sites of distant metastasis, and bone metastasis causes skeletal-related events (SREs) that impair quality of life and portend poor prognosis. Bone metastasis arises not from invasive tumour cells alone but through mutual adaptation and co-evolution between tumour cells and the bone microenvironment. A key mechanism of immune evasion is the establishment of an immunosuppressive microenvironment, wherein tumour-derived cytokines, metabolic reprogramming, and extracellular vesicles drive M2 macrophage polarization, CD8+ T-cell exhaustion, regulatory T-cell enrichment, and natural killer cell dysfunction. Transforming growth factor-β (TGF-β) released during the “tumour-bone” vicious cycle further amplifies local immunosuppression, and metabolic reprogramming depletes glucose and amino acids while accumulating lactate, directly impairing effector T-cell function. Immune checkpoint inhibitor (ICI) therapy shows limited efficacy in bone metastases; however, combination strategies including bone-protective agents (denosumab, bisphosphonates), metabolic modulators, cytokine- or extracellular vesicle-targeted agents, novel nanodelivery systems, and engineered cell therapies demonstrate encouraging preclinical and early clinical promise for reversing immunosuppression. Translation still faces major challenges, including microenvironmental heterogeneity, a lack of bone-specific biomarkers, combination-related toxicity, and delivery bottlenecks. This review aims to synthesize the mechanisms underlying the immunosuppressive bone-metastasis microenvironment and to appraise current and emerging combination strategies, thereby informing individualized treatment for patients with bone metastases.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.